Literature DB >> 2466791

Nucleotide and deduced amino acid sequences for the four variable domains of the major outer membrane proteins of the 15 Chlamydia trachomatis serovars.

Y Yuan1, Y X Zhang, N G Watkins, H D Caldwell.   

Abstract

The amino acid sequences of major outer membrane proteins (MOMPs) from Chlamydia trachomatis serovars A, B, C, L1, and L2 are predominantly conserved but have four variable domains (VDs) in which major neutralizing and serotyping antigenic determinants are located. Because these MOMP VDs are primarily responsible for antigenic differences between serovars and are associated with important immunological and biological properties, we undertook studies focused on defining these sequences within the MOMPs of all 15 C. trachomatis serovars. We used oligonucleotide primer extension sequencing of MOMP mRNA to determine the nucleotide and deduced amino acid sequences of the four MOMP VDs of the 15 C. trachomatis serovars. Comparative amino acid sequence homologies of all four domains separated the serovars into three groups: group 1, serovars B, Ba, D, E, L1, and L2; group 2, serovars G and F; and group 3, serovars A, C, H, I, J, K, and L3. Hydrophilicity and charge values for each domain were determined. The MOMP VDs of given serovars with the greatest total hydrophilicity and charge values were found to be the location of antigenic determinants recognized by MOMP-specific monoclonal antibodies. These findings should be useful for predicting MOMP antigenic determinants and testing the antigenic properties of these VDs by using synthetic peptides corresponding to each MOMP VD. The potential usefulness of the VD sequence information is discussed in relation to the development of defined synthetic peptides and oligonucleotides that may be used to develop new serological and diagnostic assays for C. trachomatis infections.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2466791      PMCID: PMC313226          DOI: 10.1128/iai.57.4.1040-1049.1989

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  17 in total

1.  Rapid determination of 16S ribosomal RNA sequences for phylogenetic analyses.

Authors:  D J Lane; B Pace; G J Olsen; D A Stahl; M L Sogin; N R Pace
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

2.  Prediction of protein antigenic determinants from amino acid sequences.

Authors:  T P Hopp; K R Woods
Journal:  Proc Natl Acad Sci U S A       Date:  1981-06       Impact factor: 11.205

3.  Piliation control mechanisms in Neisseria gonorrhoeae.

Authors:  S Bergström; K Robbins; J M Koomey; J Swanson
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

Review 4.  New knowledge of chlamydiae and the diseases they cause.

Authors:  J T Grayston; S Wang
Journal:  J Infect Dis       Date:  1975-07       Impact factor: 5.226

5.  Role of disulfide bonding in outer membrane structure and permeability in Chlamydia trachomatis.

Authors:  P Bavoil; A Ohlin; J Schachter
Journal:  Infect Immun       Date:  1984-05       Impact factor: 3.441

6.  Immunotyping of Chlamydia trachomatis with monoclonal antibodies.

Authors:  S P Wang; C C Kuo; R C Barnes; R S Stephens; J T Grayston
Journal:  J Infect Dis       Date:  1985-10       Impact factor: 5.226

7.  Rapid synthesis of long-chain deoxyribooligonucleotides by the N-methylimidazolide phosphotriester method.

Authors:  V A Efimov; A A Buryakova; S V Reverdatto; O G Chakhmakhcheva
Journal:  Nucleic Acids Res       Date:  1983-12-10       Impact factor: 16.971

8.  Differential effect of trypsin on infectivity of Chlamydia trachomatis: loss of infectivity requires cleavage of major outer membrane protein variable domains II and IV.

Authors:  H Su; Y X Zhang; O Barrera; N G Watkins; H D Caldwell
Journal:  Infect Immun       Date:  1988-08       Impact factor: 3.441

9.  Monoclonal antibodies to Chlamydia trachomatis: antibody specificities and antigen characterization.

Authors:  R S Stephens; M R Tam; C C Kuo; R C Nowinski
Journal:  J Immunol       Date:  1982-03       Impact factor: 5.422

10.  Purification and partial characterization of the major outer membrane protein of Chlamydia trachomatis.

Authors:  H D Caldwell; J Kromhout; J Schachter
Journal:  Infect Immun       Date:  1981-03       Impact factor: 3.441

View more
  108 in total

1.  Phylogenetic analysis of Chlamydia trachomatis.

Authors:  D Dean; K Millman
Journal:  Infect Immun       Date:  1999-02       Impact factor: 3.441

2.  High-resolution genotyping of Chlamydia trachomatis from recurrent urogenital infections.

Authors:  L N Pedersen; H O Kjaer; J K Møller; T F Orntoft; L Ostergaard
Journal:  J Clin Microbiol       Date:  2000-08       Impact factor: 5.948

3.  Urogenital Chlamydia trachomatis serovars in men and women with a symptomatic or asymptomatic infection: an association with clinical manifestations?

Authors:  S A Morré; L Rozendaal; I G van Valkengoed; A J Boeke; P C van Voorst Vader; J Schirm; S de Blok; J A van Den Hoek; G J van Doornum; C J Meijer; A J van Den Brule
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

4.  Isolation in endothelial cell cultures of chlamydia trachomatis LGV (Serovar L2) from a lymph node of a patient with suspected cat scratch disease.

Authors:  M Maurin; D Raoult
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

5.  Population-based genetic and evolutionary analysis of Chlamydia trachomatis urogenital strain variation in the United States.

Authors:  Kim Millman; Carolyn M Black; Robert E Johnson; Walter E Stamm; Robert B Jones; Edward W Hook; David H Martin; Gail Bolan; Simon Tavaré; Deborah Dean
Journal:  J Bacteriol       Date:  2004-04       Impact factor: 3.490

6.  Chlamydia trachomatis developmentally regulated protein is homologous to eukaryotic histone H1.

Authors:  T Hackstadt; W Baehr; Y Ying
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-01       Impact factor: 11.205

Review 7.  Diagnosis and assessment of trachoma.

Authors:  Anthony W Solomon; Rosanna W Peeling; Allen Foster; David C W Mabey
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

8.  Immunization with the attenuated plasmidless Chlamydia trachomatis L2(25667R) strain provides partial protection in a murine model of female genitourinary tract infection.

Authors:  Norma Olivares-Zavaleta; William Whitmire; Donald Gardner; Harlan D Caldwell
Journal:  Vaccine       Date:  2009-12-08       Impact factor: 3.641

9.  Detection of Chlamydia pneumoniae-specific antibodies binding to the VD2 and VD3 regions of the major outer membrane protein.

Authors:  Marcus Klein; Arne Kötz; Katussevani Bernardo; Martin Krönke
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

10.  Differentiation of Chlamydia spp. by sequence determination and restriction endonuclease cleavage of RNase P RNA genes.

Authors:  B Herrmann; O Winqvist; J G Mattsson; L A Kirsebom
Journal:  J Clin Microbiol       Date:  1996-08       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.